Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Regeneus Ltd. ( (AU:CMB) ).
Cambium Bio Limited has announced the application for quotation of 4,139,650 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of a previously announced transaction, and it signifies a strategic step in enhancing the company’s market presence and liquidity, potentially impacting its stakeholders by increasing the availability of its shares for trading.
More about Regeneus Ltd.
YTD Price Performance: -12.50%
Average Trading Volume: 24,654
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$4.95M
Find detailed analytics on CMB stock on TipRanks’ Stock Analysis page.